Clinical Outcomes and Healthcare Resource Utilization in a Real-World Population Reflecting the DAPA-CKD Trial Participants

INTRODUCTION: The DAPA-CKD trial assessed dapagliflozin in patients with chronic kidney disease (CKD) with or without type 2 diabetes (T2D). To aid interpretation of results, renal and cardiovascular outcomes plus healthcare resource utilization (HCRU) and costs were assessed in a real-world populat...

詳細記述

保存先:
書誌詳細
出版年:Adv Ther
主要な著者: Olufade, Tope, Lamerato, Lois, Sánchez, Juan José García, Jiang, Like, Huang, Joanna, Nolan, Stephen, Rangaswami, Janani
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2021
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889671/
https://ncbi.nlm.nih.gov/pubmed/33474707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01609-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料